Advertisement

Topics

Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk ...

02:06 EDT 5 Jul 2017 | BioMedReports - Blog

Opdivo (nivolumab) demonstrates superior recurrence-free survival versus Yervoy (ipilimumab) in Adjuvant Setting in CheckMate -238

Read more...

Original Article: Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk ...

NEXT ARTICLE

More From BioPortfolio on "Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...